1. Sandra Poole

    0 Comments Leave a Comment

    1-2 of 2
    1. Mentioned In 2 Articles

    2. ViaCyte Appoints Sandra E. Poole to Board of Directors

      ViaCyte Appoints Sandra E. Poole to Board of Directors
      SAN DIEGO, June 27, 2019 /PRNewswire/ -- ViaCyte, Inc., a privately-held regenerative medicine company, today announced the appointment of Sandra E. Poole to the Company's Board of Directors. Ms. Poole brings more than 25 years of biopharmaceutical experience in product development, from research through commercialization, to ViaCyte's team...
      Read Full Article
    3. Retrophin Appoints Sandra E. Poole to Board of Directors

      Retrophin Appoints Sandra E. Poole to Board of Directors
      SAN DIEGO, May 13, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (RTRX) today announced the appointment of Sandra E. Poole to the Company's Board of Directors, effective immediately. Ms. Poole brings more than 25 years of biopharmaceutical industry experience in manufacturing strategy, including chemistry, manufacturing and controls (CMC), technical operations, and product development from research through commercialization...
      Read Full Article
    4. 1-2 of 2
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content